Intelligent Investor

Genetic Technologies Limited (ASX: GTG) - Announcements

- Current share price for GTG : $0.120

ASX company news and announcements for Genetic Technologies Limited (GTG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Technologies Limited (GTG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Technologies Limited (GTG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Technologies Limited (GTG)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$16 Commitments Test Entity - Third Quarter Report 21 Apr 2004 3:10PM $0.415 $0.120 $0.120 fallen by 71.08%
$16 Third Progress Report 13 Apr 2004 10:11AM $0.435 $0.120 $0.120 fallen by 72.41%
$16 New Patents Awarded in Canada 29 Mar 2004 9:41AM $0.435 $0.120 $0.120 fallen by 72.41%
$16 Granted Accreditation to Provide DNA Forensic Testing 26 Mar 2004 8:30AM $0.430 $0.120 $0.120 fallen by 72.09%
$16 Nanogen License - Additional Value Realized 26 Feb 2004 2:48PM $0.510 $0.120 $0.120 fallen by 76.47%
$16 Grants License to LabCorp of USA 9 Feb 2004 10:25AM $0.510 $0.120 $0.120 fallen by 76.47%
$16 Grants First Commercial Licence in Canada 31 Dec 2003 9:58AM $0.480 $0.120 $0.120 fallen by 75%
$16 Expands in New Zealand 22 Dec 2003 10:44AM $0.465 $0.120 $0.120 fallen by 74.19%
$16 Grants license to Kings College London 16 Dec 2003 9:09AM $0.475 $0.120 $0.120 fallen by 74.74%
$16 Law Suits against Nuvelo & Covance now settled 17 Nov 2003 10:45AM $0.560 $0.120 $0.120 fallen by 78.57%
$16 Law Suits against Nuvelo & Covance now settled 17 Nov 2003 10:45AM $0.560 $0.120 $0.120 fallen by 78.57%
$16 Commitments Test Entity - First Quarter Report 20 Oct 2003 3:21PM $0.540 $0.120 $0.120 fallen by 77.78%
$16 New Strategic Alliance with Perth-based Foundation 14 Oct 2003 3:30PM $0.670 $0.120 $0.120 fallen by 82.09%
$16 Trading Halt 14 Oct 2003 9:55AM $0.670 $0.120 $0.120 fallen by 82.09%
$16 Trading Halt 14 Oct 2003 9:55AM $0.670 $0.120 $0.120 fallen by 82.09%
$16 GTG Grants First License in New Zealand 11 Sep 2003 9:51AM $0.720 $0.120 $0.120 fallen by 83.33%
$16 Appointed to commercialise new gene invention 5 Sep 2003 10:14AM $0.760 $0.120 $0.120 fallen by 84.21%
$16 Raises $10 million 25 Aug 2003 9:41AM $0.780 $0.120 $0.120 fallen by 84.62%
$16 Trading Halt 21 Aug 2003 3:48PM $0.730 $0.120 $0.120 fallen by 83.56%
$16 Trading Halt 21 Aug 2003 3:48PM $0.730 $0.120 $0.120 fallen by 83.56%
$16 Grants license to Quest Diagnostics of USA 21 Aug 2003 10:18AM $0.730 $0.120 $0.120 fallen by 83.56%
$16 Commitments Test Entity - Fourth Quarter Report 24 Jul 2003 12:45PM $0.570 $0.120 $0.120 fallen by 78.95%
$16 Collaborative Program To Identify Genetic Markers 26 Jun 2003 9:41AM $0.495 $0.120 $0.120 fallen by 75.76%

751 - 773 of 773 results

Page 31 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.